1. Increased CCL19 expression is associated with progression in cervical cancer
   Xiaoshu Zhang et al, 2017, Oncotarget CrossRef
2. Novel Genomic Biomarker Candidates for Cervical Cancer As Identified by Differential Co-Expression Network Analysis
   Medi Kori et al, 2019, OMICS: A Journal of Integrative Biology CrossRef
3. The adaptor SASH1 acts through NOTCH1 and its inhibitor DLK1 in a 3D model of lumenogenesis involving CEACAM1
   Kandis Stubblefield et al, 2017, Experimental Cell Research CrossRef
4. CircRNA Circ-ITCH Inhibits the Proliferation and Invasion of Glioma Cells Through Targeting the miR-106a-5p/SASH1 Axis
   Wei Chen et al, 2021, Cell Transplantation CrossRef
5. The emerging and diverse roles of the SLy/SASH1‐protein family in health and disease—Overview of three multifunctional proteins
   Jennifer Jaufmann et al, 2021, The FASEB Journal CrossRef
6. SASH1 mediates sensitivity of breast cancer cells to chloropyramine and is associated with prognosis in breast cancer
   Joshua T. Burgess et al, 2016, Oncotarget CrossRef
7. Pan-Cancer Integrated Analysis Identification of SASH3, a Potential Biomarker That Inhibits Lung Adenocarcinoma Progression
   Xi Chen et al, 2022, Frontiers in Oncology CrossRef
8. Comprehensive analysis of gene expression profiles reveals novel candidates of chemotherapy resistant factors in canine lymphoma
   Miyu Suenaga et al, 2017, The Veterinary Journal CrossRef
9. Downregulated SASH1 expression indicates poor clinical prognosis in gastric cancer
   Nan Zhou et al, 2018, Human Pathology CrossRef
10. SASH1 is a prognostic indicator and potential therapeutic target in non-small cell lung cancer
    Joshua T. Burgess et al, 2020, Scientific Reports CrossRef
11. Focal adhesion kinase inhibitor BI 853520 inhibits cell proliferation, migration and EMT process through PI3K/AKT/mTOR signaling pathway in ovarian cancer
    Hong Li et al, 2021, Discover Oncology CrossRef
12. A Comprehensive Understanding of the Anticancer Mechanisms of FDY2004 Against Cervical Cancer Based on Network Pharmacology
    Ho-Sung Lee et al, 2021, Natural Product Communications CrossRef
13. HMGB1 contributes to SASH1 methylation to attenuate astrocyte adhesion
    Ronghua Wu et al, 2019, Cell Death & Disease CrossRef
14. SASH1, a potential therapeutic target for cancer—reply
    Nan Zhou, 2018, Human Pathology CrossRef
15. Parthenolide inhibits the proliferation and migration of cervical cancer cells via FAK/GSK3β pathway
    Liru Huang et al, 2023, Cancer Chemotherapy and Pharmacology CrossRef